You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Grade Epithelial Ovarian Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

Recruiting
  • Epithelial Ovarian Cancer
  • Mannheim, Baden-Württemberg, Germany
  • +2 more
Jun 15, 2022

High-Grade Ovarian Cancer Terms of Homologous Recombination

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Standard of care
  • (no location specified)
Oct 7, 2022

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

Platinum-resistant Ovarian Cancer Trial in China (IN10018 in combination with PLD)

Recruiting
  • Platinum-resistant Ovarian Cancer
  • IN10018 in combination with PLD
  • Anyang, China
  • +6 more
Sep 20, 2022

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 11, 2022

High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

Not yet recruiting
  • High Grade Serous Ovarian Cancer
  • Blood sample and tissue sample
  • Montpellier, France
    NOUGARET Stephanie
Oct 10, 2023

Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jul 18, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Early Detection of High Grade Serous Epithelial Ovarian Cancer

Active, not recruiting
  • Epithelial Ovarian Cancer
  • DNA Methylation
  • Dallas, Texas
    Baylor University Medical Center
Jan 31, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (18F-DCFPyL)

Recruiting
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
  • 18F-DCFPyL
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 31, 2021

CINSARC Genomic Signature as Predictor of Resectability of

Completed
  • Ovarian Adenocarcinoma
  • CINSARC signature
  • Toulouse, France
    Institut Claudius Regaud Institut Universitaire du cancer Toulou
Dec 22, 2022

Ovarian Cancer Trial in Kelowna, Vancouver, Kingston (Durvalumab, BA3011, BA3021)

Recruiting
  • Ovarian Cancer
  • Kelowna, British Columbia, Canada
  • +4 more
Nov 14, 2022

Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Speiser-catheter for uterine and tubal lavage)

Completed
  • Ovarian Epithelial Cancer
  • +2 more
  • Speiser-catheter for uterine and tubal lavage
  • Graz, Austria
  • +8 more
Sep 1, 2022

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Chromosomal Instability in Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +7 more
  • Testing for chromosomal instability (CIN)
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

Ovarian Cancer, High Grade Ovarian Serous Trial in New York (PET/MRI, Contrast enhanced CT)

Active, not recruiting
  • Ovarian Cancer
  • High Grade Ovarian Serous
  • PET/MRI
  • Contrast enhanced CT
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Mar 2, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (3 cycles chemo instead of 6 cycles chemo, 6 cycles

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • 3 cycles chemotherapy instead of 6 cycles chemotherapy
  • 6 cycles chemotherapy
  • (no location specified)
Jul 12, 2022

BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

Active, not recruiting
  • BRCA1 Mutation
  • +4 more
  • Talazoparib Oral Capsule
  • Providence, Rhode Island
  • +1 more
Nov 30, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

miRNAs in High Grade Serous Ovarian Cancer

Recruiting
  • High Grade Serous Ovarian Cancer
    • Bologna, Bo, Italy
      IRCCS- Azienda Ospedaliera-Universitaria di Bologna
    Dec 3, 2021